サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1455792

フラボノイド配糖体の世界市場-2024-2031年

Global Flavonoid Glycosides Market - 2024-2031

出版日
ページ情報
英文 213 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
フラボノイド配糖体の世界市場-2024-2031年
出版日: 2024年03月26日
発行: DataM Intelligence
ページ情報: 英文 213 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

フラボノイド配糖体の世界市場は、2023年に3億8,710万米ドルに達し、2031年には6億4,060万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは6.5%で成長する見込みです。

合成添加物や人工物質に対する懸念から、消費者の間で天然成分を使用した製品に対する嗜好が高まっています。植物や果実由来のフラボノイド配糖体は、天然でクリーンラベルの製品を求めるこの動向に合致しています。その結果、フラボノイド配糖体含有製品に対する需要が高まり、市場の成長を牽引しています。

現在進行中の研究開発は、フラボノイド配糖体の健康上の利点と治療の可能性を探ることに重点を置いています。フラボノイド配糖体の抗酸化作用、抗炎症作用、抗菌作用が研究で実証され、医薬品、栄養補助食品、機能性食品への利用が増加し、さまざまな産業におけるフラボノイド配糖体の用途が拡大しています。

例えば、2023年9月5日、エボニックはSPACE 2023で単胃ポートフォリオの新たな強化を発表しました。それはPhytriCare IMの紹介である：エボニックのポートフォリオに新たに加わったこのプレミックスは、フォトジェニック製品のデビューとなります。フラボノイドが配合されており、母豚、産卵鶏、乳牛の炎症管理に効果が期待できます。

フラボノイド配糖体は抗酸化作用があるため、栄養補助食品の有効成分として一般的に使用されています。消費者が栄養ニーズを満たすためにますますサプリメントを利用するようになるにつれて、フラボノイド配糖体を含有するサプリメントの需要は増加傾向にあり、市場の成長に寄与しています。メーカーは、消費者の嗜好に応えるため、フラボノイド配糖体を含む天然成分を使用した新製品を発売することで対応しています。このような天然でクリーンラベルの製品への注目は、北米の市場成長を後押ししています。

ダイナミクス

機能性食品と栄養補助食品に対する需要の高まり

機能性食品と栄養補助食品の健康効果に対する消費者の意識が高まるにつれて、フラボノイド配糖体のような生物活性化合物を豊富に含む製品に対する需要も相応に増加しています。飲食品メーカーはこうした需要に対応するため、こうした化合物を含む製品をさらに投入する可能性が高く、それによって市場が拡大します。

機能性食品と栄養補助食品の需要は、食品業界における技術革新と製品開発を促進します。メーカーは、フラボノイド配糖体のような生物活性化合物の生物学的利用能と効能を高めるために、新しい製剤と送達システムを絶えず模索しています。このような技術革新は、消費者に幅広い選択肢を提供することで市場の成長を促進しています。

例えば、2023年9月14日、Uncle Matt's Organic社は、体に良い飲料のラインナップに新たな製品、スーパーフルーツパンチを追加しました。ダークスイートチェリー、ブラックエルダーベリー、ブルーベリーの組み合わせで作られたこの機能性ジュースは、抗酸化物質、ポリフェノール、フラボノイドを豊富に含んでいます。健康志向の消費者向けに設計されたUncle Mattのパンチは、1杯8オンス当たりわずか45キロカロリーを誇り、砂糖や香料を一切加えず、保存料も一切使用していません。

医薬品業界における用途の拡大

フラボノイド配糖体は、その治療特性から、伝統的に様々な文化圏の漢方薬に使用されています。自然療法やハーブサプリメントへの嗜好が高まるにつれ、フラボノイド配糖体を含む医薬品への需要が高まっています。この需要の増加がフラボノイド配糖体市場の成長に直接寄与しています。

製薬会社は、フラボノイド配糖体の薬効と様々な疾患の治療や予防への応用の可能性を探るため、研究開発に多額の投資を行っています。例えば、2024年2月29日、Ingredients by Nature社は、BioFactors Journal誌に、複数の特許を取得した柑橘系フラボノイドブレンドであるEriominに焦点を当てた実験的研究を発表しました。この研究では、エリオミンが肝機能を促進し、加齢に伴う肝臓の悩みを解決する可能性について掘り下げています。

限られた原料の入手可能性

フラボノイド配糖体は、主に果物、野菜、ハーブなどの天然由来です。気候変動、自然災害、季節変動などの要因は、これらの原材料のサプライチェーンを混乱させる可能性があります。原料の供給が途絶えると生産量が変動し、市場の成長に影響を及ぼす可能性があります。市場関係者は、複数の地域から原材料を調達する際の課題に直面し、供給不足を招き、市場成長の妨げとなります。

フラボノイド配糖体を含む植物には特定の収穫期があり、その時期は原料が豊富で品質も最適です。原料の入手可能性が低下すると、安定した生産レベルを維持することが課題となります。市場関係者は、季節変動の影響を緩和するために原材料を備蓄し、貯蔵設備に投資する必要があり、生産コストを増加させ、市場成長に影響を与える可能性があります。

目次

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 機能性食品と栄養補助食品に対する需要の高まり
      • 製薬業界における用途の拡大
    • 抑制要因
      • 原材料の入手可能性の制限
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 タイプ別

  • ケルセチン-3-O-ルチノシド（Q-rut）
  • ケルセチン-3-O-ガラクトシド（Q-gal）
  • ケルセチン-3-O-グルコシド（Q-glc）
  • ケルセチン-3-O-グルクロニド（Q-glr）
  • ケンフェロール-3-O-グルコシド（K-glc）
  • その他

第8章 供給源別

  • 柑橘果実
  • ソバ
  • タマネギ
  • その他

第9章 用途別

  • 抗がん剤
  • 酸化防止剤
  • 抗炎症
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Merck KGaA
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Merck KGaA
  • Lifecare Neuro Products Limited
  • Indena S.p.A.
  • Cayman Chemical Company
  • Extrasynthese
  • INDOFINE Chemical Company, Inc.
  • SMPNutra
  • Taylor & Francis Group, LLC.
  • Ayur-vana
  • Ingredion Incorporated[List not Exhaustive]

第13章 付録

目次
Product Code: FB8251

Overview

Global Flavonoid Glycosides Market reached US$ 387.1 million in 2023 and is expected to reach US$ 640.6 million by 2031, growing with a CAGR of 6.5% during the forecast period 2024-2031.

Growing preference among consumers for products made with natural ingredients, driven by concerns about synthetic additives and artificial substances. Flavonoid glycosides, derived from plants and fruits, align with this trend toward natural and clean-label products. As a result, there is increasing demand for flavonoid glycoside-containing products, which is driving market growth.

Ongoing research and development efforts are focused on exploring the health benefits and therapeutic potential of flavonoid glycosides. Studies have demonstrated the antioxidant, anti-inflammatory, and antimicrobial properties of these compounds, leading to their increased use in pharmaceuticals, nutraceuticals, and functional foods expanding the applications of flavonoid glycosides in various industries.

For instance, on September 5, 2023, Evonik introduced new enhancements to its monogastric portfolio at SPACE 2023. It is introducing PhytriCare IM: Evonik's newest addition to the portfolio, this premix marks the debut of photogenic products. It is infused with flavonoids, it offers potential benefits in inflammation management for sows, laying hens, and dairy cows.

Flavonoid glycosides are commonly used as active ingredients in dietary supplements due to their antioxidant properties. As consumers increasingly turn to supplements to meet their nutritional needs, the demand for flavonoid glycoside-containing supplements is on the rise, contributing to market growth. Manufacturers are responding by introducing new products made with natural ingredients, including flavonoid glycosides, to cater to consumer preferences. This focus on natural and clean-label products is boosting market growth in North America.

Dynamics

Rising Demand for Functional Foods and Nutraceuticals

As consumer awareness about the health benefits of functional foods and nutraceuticals grows, there is a corresponding increase in demand for products enriched with bioactive compounds such as flavonoid glycosides. Food and beverage manufacturers are likely to introduce more products containing these compounds to cater to this demand, thereby expanding the market.

The demand for functional foods and nutraceuticals encourages innovation and product development within the food industry. Manufacturers are continually exploring new formulations and delivery systems to enhance the bioavailability and efficacy of bioactive compounds like flavonoid glycosides. This innovation fuels market growth by offering consumers a wider range of products to choose from.

For instance, on September 14, 2023, Uncle Matt's Organic introduced its new addition to the better-for-you beverage lineup: Superfruit Punch. It is crafted with a combination of dark sweet cherries, black elderberry, and blueberries, this functional juice is rich in antioxidants, polyphenols, and flavonoids. It is designed for health-conscious consumers, Uncle Matt's punch boasts just 45 calories per 8-oz serving, with no added sugars or flavors, and absolutely no preservatives.

Expanding Applications in the Pharmaceutical Industry

Flavonoid glycosides are traditionally used in herbal medicine systems across various cultures for their therapeutic properties. With the growing preference for natural remedies and herbal supplements, there is an increased demand for pharmaceutical products containing flavonoid glycosides. This increased demand directly contributes to the growth of the flavonoid glycosides market.

Pharmaceutical companies are investing heavily in research and development to explore the medicinal properties of flavonoid glycosides and their potential applications in the treatment and prevention of various diseases. For instance, on February 29, 2024, Ingredients by Nature announced the publication of its experimental research in the BioFactors Journal, focusing on Eriomin, a multi-patented citrus flavonoid blend. The study delves into the potential of Eriomin to promote liver function and address age-related liver concerns.

Limited Availability of Raw Materials

Flavonoid glycosides are primarily derived from natural sources such as fruits, vegetables, and herbs. Factors such as climate change, natural disasters, and seasonal variations can disrupt the supply chain of these raw materials. Interruption in the availability of raw materials can lead to fluctuations in production output, affecting market growth. Market players face challenges in sourcing raw materials from multiple regions, leading to supply shortages and hindering market growth.

The plants containing flavonoid glycosides have specific harvesting seasons, during which the raw materials are abundant and of optimal quality. The availability of raw materials declines, leading to challenges in maintaining consistent production levels. Market players need to stockpile raw materials and invest in storage facilities to mitigate the impact of seasonal variations, adding to production costs and potentially affecting market growth.

Segment Analysis

The global flavonoid glycosides market is segmented based on type, source, application, and region.

Increasing Demand for Antioxidant-Rich Products

Antioxidant holds the largest share of the global market. There is a growing awareness among consumers about the health benefits of antioxidants, including their role in neutralizing free radicals and reducing oxidative stress. As a result, there is a rising demand for antioxidant-rich products, such as dietary supplements, functional foods, and beverages, which contain flavonoid glycosides. This increased demand boosts market growth within the antioxidant segment.

Ongoing development focused on exploring the therapeutic potential of antioxidants in preventing and treating various diseases. Clinical studies investigating the efficacy of flavonoid glycosides and other antioxidants have generated promising results, further supporting their use in healthcare products. The positive outcomes of such research contribute to market growth within the antioxidant segment.

Geographical Penetration

Increasing Consumer Awareness and Innovations in North America

North America dominates the global flavonoid glycosides market. North America has a well-developed health and wellness industry, and consumers in the region are increasingly aware of the health benefits associated with flavonoid glycosides. There is a growing interest in natural and plant-based ingredients, including flavonoid glycosides, due to their antioxidant properties and potential health-promoting effects boosts demand for flavonoid glycoside-containing products in the region, contributing to market dominance.

North America has several major players in the food, beverage, dietary supplement, and pharmaceutical industries, which are actively involved in the production and distribution of flavonoid glycosides. These companies have extensive research and development capabilities, robust distribution networks, and strong brand recognition, enabling them to dominate the flavonoid glycosides market in the region.

COVID-19 Impact Analysis

The pandemic led to disruptions in global supply chains due to lockdown measures, travel restrictions, and workforce shortages. This disruption affected the sourcing of raw materials for flavonoid glycoside extraction, as well as the transportation of finished products. Consequently, market players faced challenges in maintaining production levels, leading to potential delays in product availability and fulfillment of orders, which could have hindered market growth.

The pandemic prompted significant shifts in consumer behavior, including changes in dietary preferences and purchasing patterns. With a heightened focus on health and wellness, consumers increasingly sought out products with immune-boosting and antioxidant properties, including those containing flavonoid glycosides. This shift in consumer demand could have bolstered market growth, as manufacturers responded by introducing new products or marketing existing ones emphasizing their flavonoid glycoside content.

Russia-Ukraine War Impact Analysis

During the conflict, disruptions occurred in the agricultural supply chains of both Russia and Ukraine, two significant exporters of raw materials used in flavonoid glycoside extraction. This disruption led to shortages and price volatility for raw materials, hindering production capabilities. Consequently, market growth was constrained due to reduced availability and increased production costs.

The conflict created geopolitical tensions and uncertainties, affecting trade relationships and international cooperation in the flavonoid glycosides market. Trade disruptions, tariffs, and export restrictions imposed by involved parties disrupted the flow of raw materials and finished products. This limited market access and increased trade barriers, negatively impacting market growth.

By Type

  • Quercetin-3-O-rutinoside (Q-rut)
  • Quercetin-3-O-galactoside (Q-gal)
  • Quercetin-3-O-glucoside (Q-glc)
  • Quercetin-3-O-glucuronide (Q-glr)
  • Kaempferol-3-O-glucoside (K-glc)
  • Others

By Source

  • Citrus Fruit
  • Buckwheat
  • Onions
  • Others

By Application

  • Anticancer
  • Antioxidant
  • Anti-inflammatory
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • On January 15, 2024, The Department of Food Chemistry and Biocatalysis at UPWr announced funding for its pioneering project through the 14th edition of the National Centre for Research and Development's "Leader" program. The innovative project, titled "Flavonoid Glycosides with a Chlorine Atom: Multifunctional, Natural Preserving Agents in Cosmetic Products," has been granted nearly 1.8 million PLN from the NCBR.
  • On December 12, 2023, Florida A&M University (FAMU) announced a groundbreaking discovery: flavonoids, natural compounds commonly found in fruits and vegetables, may present a promising new treatment avenue. It is the remarkable aspect of these compounds is their non-toxic nature and their potential to combat chemotherapy resistance in breast cancer patients.
  • On October 18, 2023, Taiyo's revolutionary enzymatic technology, the SunActive flavonoid delivery system, announced a significant leap forward for the dietary supplement industry. This patented, solvent-free innovation is enhancing the industry's capacity to introduce more potent and effective ingredients to the market, marking a significant advancement in product efficacy and quality.

Competitive Landscape

The major global players in the flavonoid glycosides market include Merck KGaA, Lifecare Neuro Products Limited, Indena S.p.A., Cayman Chemical Company, Extrasynthese, INDOFINE Chemical Company, Inc., SMPNutra, Taylor & Francis Group, LLC., Ayur-vana, and Ingredion Incorporated.

Why Purchase the Report?

  • To visualize the global flavonoid glycosides market segmentation based on type, source, application, and region, as well as understand critical commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous flavonoid glycosides market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of critical products of all the major players.

The global flavonoid glycosides market report would provide approximately 62 tables, 57 figures, and 213 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Type
  • 3.2.Snippet by Source
  • 3.3.Snippet by Application
  • 3.4.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Rising Demand for Functional Foods and Nutraceuticals
      • 4.1.1.2.Expanding Applications in the Pharmaceutical Industry
    • 4.1.2.Restraints
      • 4.1.2.1.Limited Availability of Raw Materials
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.Russia-Ukraine War Impact Analysis
  • 5.6.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Type

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2.Market Attractiveness Index, By Type
  • 7.2.Quercetin-3-O-rutinoside (Q-rut) *
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Quercetin-3-O-galactoside (Q-gal)
  • 7.4.Quercetin-3-O-glucoside (Q-glc)
  • 7.5.Quercetin-3-O-glucuronide (Q-glr)
  • 7.6.Kaempferol-3-O-glucoside (K-glc)
  • 7.7.Others

8.By Source

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 8.1.2.Market Attractiveness Index, By Source
  • 8.2.Citrus Fruit*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Buckwheat
  • 8.4.Onions
  • 8.5.Others

9.By Application

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2.Market Attractiveness Index, By Application
  • 9.2.Anticancer*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Antioxidant
  • 9.4.Anti-inflammatory
  • 9.5.Others

10.By Region

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2.Market Attractiveness Index, By Region
  • 10.2.North America
    • 10.2.1.Introduction
    • 10.2.2.Key Region-Specific Dynamics
    • 10.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1.U.S.
      • 10.2.6.2.Canada
      • 10.2.6.3.Mexico
  • 10.3.Europe
    • 10.3.1.Introduction
    • 10.3.2.Key Region-Specific Dynamics
    • 10.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1.Germany
      • 10.3.6.2.UK
      • 10.3.6.3.France
      • 10.3.6.4.Italy
      • 10.3.6.5.Russia
      • 10.3.6.6.Rest of Europe
  • 10.4.South America
    • 10.4.1.Introduction
    • 10.4.2.Key Region-Specific Dynamics
    • 10.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1.Brazil
      • 10.4.6.2.Argentina
      • 10.4.6.3.Rest of South America
  • 10.5.Asia-Pacific
    • 10.5.1.Introduction
    • 10.5.2.Key Region-Specific Dynamics
    • 10.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1.China
      • 10.5.6.2.India
      • 10.5.6.3.Japan
      • 10.5.6.4.Australia
      • 10.5.6.5.Rest of Asia-Pacific
  • 10.6.Middle East and Africa
    • 10.6.1.Introduction
    • 10.6.2.Key Region-Specific Dynamics
    • 10.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 10.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11.Competitive Landscape

  • 11.1.Competitive Scenario
  • 11.2.Market Positioning/Share Analysis
  • 11.3.Mergers and Acquisitions Analysis

12.Company Profiles

  • 12.1.Merck KGaA*
    • 12.1.1.Company Overview
    • 12.1.2.Product Portfolio and Description
    • 12.1.3.Financial Overview
    • 12.1.4.Key Developments
  • 12.2.Merck KGaA
  • 12.3.Lifecare Neuro Products Limited
  • 12.4.Indena S.p.A.
  • 12.5.Cayman Chemical Company
  • 12.6.Extrasynthese
  • 12.7.INDOFINE Chemical Company, Inc.
  • 12.8.SMPNutra
  • 12.9.Taylor & Francis Group, LLC.
  • 12.10.Ayur-vana
  • 12.11.Ingredion Incorporated [List not Exhaustive]

LIST NOT EXHAUSTIVE

13.Appendix

  • 13.1.About Us and Services
  • 13.2.Contact Us